Scientists discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of ...

Scientists at Duke University's Human Vaccine Institute have made a significant advance in the quest for an HIV vaccine, successfully developing a vaccine candidate that could help the immune system ...

Here are some of the findings from UNAIDS' new report on HIV and human rights, and what they could mean for the fight against ...

Every week, 4000 young women contract HIV. Discover hidden barriers to prevention and innovative solutions that can change ...

Gilead Sciences Inc (NASDAQ: GILD) is strongly positioned to “change the face of HIV” in 2025, according to its chairman and ...

The government provides HIV medicines free of charge. Yet in one Indigenous territory, cases and deaths are increasing at an ...

Promising new drugs to prevent and treat HIV have the potential to transform the response to the disease. But getting these ...

Regardless of CD4 count, AIDS can also be identified if a person gets cancer or opportunistic infections, which are uncommon in people without HIV. As long as treatment begins early enough ...

EVEN though public health facilities continue providing HIV and AIDS medication with more players ... but those who started treatment in the test and treat programme, a lot of them are not in ...

Health officials overseeing the city of Wuhan in China have been forced to stop HIV clinics from uploading results to a new digital system for test sharing after two HIV positive patients were refused ...

Lenacapavir has been described as a pathbreaking advancement in HIV care and is being heralded as an early vaccine-like innovation in HIV treatment.